Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Fuchs Petrolub SE VZO

Start price
Target price
Perf. (%)
€39.48
03.01.22
€45.00
03.01.23
-0.10%
20.01.22

Good culture
Medium risks for its business
Sustainability is important
buy
Aecom Tech.c.(del.)

Start price
Target price
Perf. (%)
€68.50
02.01.22
€70.00
02.01.23
-8.57%
24.01.22

Higher EBIT margin than peer group
Fair valuation
ROE higher than 10% per year
Good rating
buy
Roku

Start price
Target price
Perf. (%)
€198.52
30.12.21
€250.00
30.12.22
-81.15%
30.12.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
buy
NRX Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.60
29.12.21
-
29.12.22
-3.04%
08.01.22

Capable Management
Could be worthwhile Investment >10% per year
Innovative
Few uniques
buy
UFP Industries Inc.

Start price
Target price
Perf. (%)
€81.50
28.12.21
€85.00
28.12.22
-8.71%
29.12.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Aalberts Industries NV

Start price
Target price
Perf. (%)
€57.94
28.12.21
€62.00
28.12.22
-36.61%
29.12.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
ROE lower than 10% per year
Higher risks for its business
buy
Tandem Diabetes Care Inc

Start price
Target price
Perf. (%)
€136.00
28.12.21
€142.00
28.12.22
-70.42%
29.12.22

Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
buy
Encavis AG

Start price
Target price
Perf. (%)
€15.71
28.12.21
€17.00
28.12.22
-14.58%
06.01.22

Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
buy
Nemetschek SE

Start price
Target price
Perf. (%)
€114.40
28.12.21
€125.00
28.12.22
-18.04%
08.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
buy
United Internet

Start price
Target price
Perf. (%)
€34.95
28.12.21
-
28.12.22
-46.15%
29.12.22

buy
Kinross Gold Corp.

Start price
Target price
Perf. (%)
€4.97
28.12.21
-
28.12.22
-3.04%
08.01.22

Could be worthwhile Investment >10% per year
buy
Opko Health Inc.

Start price
Target price
Perf. (%)
€4.65
28.12.21
-
28.12.22
-75.54%
29.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
buy
Reliance Steel & Aluminum Corp.

Start price
Target price
Perf. (%)
€142.00
28.12.21
-
28.12.22
33.80%
29.12.22

buy
Bpost S.A. A

Start price
Target price
Perf. (%)
€7.62
27.12.21
-
27.12.25
-56.82%
11.03.24

Could be worthwhile Investment >10% per year
buy
Uniqure B.V.

Start price
Target price
Perf. (%)
€19.00
27.12.21
-
27.12.22
8.55%
28.12.22

Could be worthwhile Investment >10% per year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€143.65
27.12.21
-
27.12.22
-9.78%
09.01.22

Risky Investment
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€37.99
27.12.21
€42.00
27.12.22
-5.05%
28.12.22

Could be worthwhile Investment >10% per year
Krones AG

Start price
Target price
Perf. (%)
€96.30
27.12.21
-
27.12.22
-19.63%
15.03.22

buy
New Oriental Education & Technology Group

Start price
Target price
Perf. (%)
€1.75
27.12.21
-
27.12.25
118.29%
23.01.23

Could be worthwhile Investment >10% per year
buy
Hapag Lloyd AG

Start price
Target price
Perf. (%)
€259.40
27.12.21
-
27.12.22
-25.48%
28.12.22

Good culture
Some uniques
Could be worthwhile Investment >10% per year
Capable Management
buy
Rational AG

Start price
Target price
Perf. (%)
€899.00
27.12.21
-
27.12.22
-38.15%
28.12.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€228.00
25.12.21
€260.00
25.12.22
-15.86%
06.01.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Standard Investments for future growth
Capable Management
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€224.75
25.12.21
€260.00
25.12.22
-14.41%
06.01.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
buy
Schaeffler AG

Start price
Target price
Perf. (%)
€7.22
23.12.21
-
23.12.22
-25.97%
25.08.22

buy
ProSiebenSat.1 Media SE

Start price
Target price
Perf. (%)
€13.99
23.12.21
-
23.12.22
-43.53%
25.08.22